The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


10 Mg/Ml Eye Drops Suspension

Novartis Europharm LimitedEU/1/00/129/002

Main Information

Trade NameAZOPT
Active SubstancesBRINZOLAMIDE
Strength10 Mg/Ml
Dosage FormEye Drops Suspension
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/00/129/002

Group Information

ATC CodeS01EC04 brinzolamide


Licence Issued09/03/2000
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back